SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Bliss GVS Pharma Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
506197 INE416D01022 104.3299482 BLISSGVS 0.24 2,193.01 28.24 7.34 1
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales164.68190.23163.36
Other Operating Income0.000.000.00
Other Income 10.2313.5910.59
Total Income174.91203.82173.96
Total Expenditure 140.34159.96130.60
PBIDT34.5743.8643.36
Interest 1.482.715.11
PBDT33.0941.1538.25
Depreciation7.807.697.68
Tax7.5211.4112.55
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.84-2.75-3.04
Reported Profit After Tax18.6124.7921.05
Extra-ordinary Items -1.770.000.00
Adjusted Profit After Extra-ordinary item20.3824.7921.05
    
EPS (Unit Curr.)1.762.352.00
EPS (Adj) (Unit Curr.)1.762.352.00
Calculated EPS (Unit Curr.)1.762.352.00
Calculated EPS (Adj) (Unit Curr.)1.762.352.00
Calculated EPS (Ann.) (Unit Curr.)7.049.397.98
Calculated EPS (Adj) (Ann.) (Unit Curr.)7.049.397.98
Book Value (Unit Curr.)0.000.000.00
Dividend (%)50.000.000.00
Equity10.5810.5610.55
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)20.9923.0626.54
PBDTM(%)20.0921.6323.41
PATM(%)11.3013.0312.89